JavierAlonso-LlamazaresMD

Dermatology • Coconut Grove, FL

Physician

Join to view full profile

Dr. Alonso-Llamazares is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alonso-Llamazares' full profile

Already have an account?

Office
475 Biltmore Way
Ste 308
Coconut Grove, FL 33134
Phone+1 305-443-2994

Fax+1 305-443-9725

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2003 - 2006
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2002 - 2003
Universidad de Navarra Faculty of MedicineClass of 1989

Certifications & Licensure

FL State Medical License 2006 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 May 08
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris
JAMA Dermatology. 2024-11-01
1 citations
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris
Journal of the American Academy of Dermatology. 2024-08-01
10 citations
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia
Journal of the American Academy of Dermatology. 2024-05-01

Lectures

Gross and Microscopic Symposium
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Professional Memberships

American Academy of Dermatology - AAD
Fellow